This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joan Stephenson, PhD

JAMA. 2000;284:822.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A new international network will develop and test promising strategies for preventing the spread of HIV/AIDS, the NIH announced last month at the 13th International AIDS Conference in Durban, South Africa.

The HIV Prevention Trials Network (HPTN) will focus on six areas of prevention research aimed at blocking or reducing HIV infection: drugs that prevent mother-to-child transmission; microbicides designed for vaginal and/or rectal use, to prevent sexual transmission; interventions to reduce high-risk behaviors; programs to curb HIV spread related to injection drug use; measures to control other sexually transmitted diseases; and antiretroviral therapy to protect high-risk uninfected adults and victims of sexual assault.

The network comprises a core group/operations center, a central laboratory, and a statistical and data coordinating center (all in the United States), as well as research sites in Africa, Asia, Europe, South America, and the United States.

"The HPTN establishes a strong foundation of . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?